ELISA: 1 μg/mL. Western Blot: 1 μg/mL. Immunohistochemistry on Paraffin Sections: 10 μg/mL. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Konzentration
0.5 mg/mL
Buffer
PBS containing 0.01 % Sodium Azide as preservative and 50 % Glycerol as stabilizer.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
Target
VAMP5
(Vesicle-Associated Membrane Protein 5 (Myobrevin) (VAMP5))
VAMP5 (Vesicle-Associated Membrane Protein 5) may participate in trafficking events that are associated with myogenesis, such as myoblast fusion and/or GLUT4 trafficking. VAMP5 is a Type IV membrane protein and it is associated with the plasma membrane as well as intracellular perinuclear and peripheral vesicular structures of myotubes and is also associated with the trans-Golgi, but not with the cis-Golgi apparatus. It is preferentially expressed in the skeletal muscle and heart, detected at lower levels in several other tissues but not in the brain.Synonyms: HSPC191, VAMP5, Vesicle-associated membrane protein 5